Disruptive strategies are essential to grow the pharma industry.
Scott Braunstein
Advertisement
Scott Braunstein is chairman and CEO of Marinus Pharmaceuticals, Inc.
Articles by Scott Braunstein
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
